Nutra Pharma shifts 62.63% voting power to Pure Raw
Control of Nutra Pharma Corp. shifted on August 21, 2026, as Pure Raw Supplies, LLC became the controlling stockholder through supervoting preferred shares.
Rhea-AI Filing Summary
NUTRA PHARMA CORP (NPHC) reports a change in control driven by a transfer of preferred stock voting power. On August 21, 2026, Rik Deitsch transferred 12,000,000 shares of the company’s Series B Preferred Stock to Pure Raw Supplies, LLC as a gift and for no consideration. These Series B shares carry supermajority voting rights that allow the holder to control the outcome of substantially all matters submitted to stockholders. As a result, Pure Raw Supplies, LLC became the controlling stockholder of the company on that date, holding 62.63% of the total voting power of Nutra Pharma’s outstanding capital stock, voting power that had previously been held by Rik Deitsch.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.01 — Changes in Control of Registrant
1 item
Item 5.01
Changes in Control of Registrant
Governance
A change in control of the company occurred, such as through a merger, takeover, or management buyout.
Key Figures
Series B Preferred Shares Transferred: 12,000,000 shares
Voting Power After Transfer: 62.63% of total voting power
Transfer Date: August 21, 2026
3 metrics
Series B Preferred Shares Transferred
12,000,000 shares
Gift transfer from Rik Deitsch to Pure Raw Supplies, LLC on August 21, 2026
Voting Power After Transfer
62.63% of total voting power
Held by Pure Raw Supplies, LLC immediately following the Series B Preferred Stock transfer
Transfer Date
August 21, 2026
Date the 12,000,000 Series B Preferred shares were transferred and change in control occurred
Key Terms
Series B Preferred Stock, supermajority voting rights, change in control, controlling stockholder
4 terms
Series B Preferred Stock financial
"transferred twelve million (12,000,000) shares of the Company’s Series B Preferred Stock"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
supermajority voting rights financial
"the shares possess supermajority voting rights that provide the holder with voting power"
change in control financial
"As a result of the transfer of the Series B Preferred Stock, a change in control of the Company occurred"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
controlling stockholder financial
"Pure Raw Supplies, LLC became the controlling stockholder of the Company"
A controlling stockholder is an individual or group that owns enough voting power in a company to shape major decisions—such as who sits on the board, whether to merge, or what strategy to pursue. Think of them as holding a majority of seats on a town council: their preferences often determine outcomes. Investors care because a controlling stockholder can push actions that benefit their interests, affect minority shareholders’ returns, and change the company’s risk and valuation.
FAQ
What change in control did NPHC disclose on August 21, 2026?
Nutra Pharma disclosed that on August 21, 2026, Rik Deitsch transferred 12,000,000 Series B Preferred shares to Pure Raw Supplies, LLC, causing a change in control as the voting power associated with those shares shifted to the transferee.
Who is now the controlling stockholder of NPHC?
Pure Raw Supplies, LLC became the controlling stockholder of Nutra Pharma Corp. on August 21, 2026, through its ownership of the Series B Preferred Stock, which carries supermajority voting rights over substantially all stockholder matters.
How much voting power does the new controlling holder have in NPHC?
Immediately after the transfer, Pure Raw Supplies, LLC held 62.63% of the total voting power of Nutra Pharma Corp.’s outstanding capital stock through its ownership of the Series B Preferred Stock.
Did NPHC receive any consideration for the preferred stock transfer?
No. The 12,000,000 Series B Preferred shares were transferred by Rik Deitsch to Pure Raw Supplies, LLC as a gift and for no consideration, meaning Nutra Pharma Corp. did not receive proceeds from this transfer.
What gives the Series B Preferred Stock at NPHC its control feature?
Under the Certificate of Designation for the Series B Preferred Stock, the shares carry supermajority voting rights that provide the holder with voting power sufficient to control substantially all matters submitted to Nutra Pharma’s stockholders for approval.
Who held NPHC’s controlling voting power before the transfer?
Before the August 21, 2026 transfer, the voting power associated with the Series B Preferred Stock—representing 62.63% of total voting power—was held by Rik Deitsch.
AI-generated analysis. How Rhea-AI works. Not financial advice.
